How much funding has Nectero Medical raised?

Nectero Medical has raised $115.5M in total funding, most recently a Series D round.

Who are Nectero Medical's investors?

Nectero Medical's investors include Boston Scientific Corporation, Shiv Chaudhary, BioStar Capital, Cadence Healthcare Ventures, Aphelion Capital.

When was Nectero Medical founded?

Nectero Medical was founded in 2017.

Where is Nectero Medical headquartered?

Nectero Medical is headquartered in Tempe, Arizona, United States.

What industry is Nectero Medical in?

Nectero Medical operates in Biotech, Healthcare, Medical Devices.

How many employees does Nectero Medical have?

Nectero Medical has 11-50 employees.

Nectero Medical

Nectero Therapeutics – Nectero Therapeutics is developing a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms (AAA).

Tempe, United States · Founded 2017 · $115.5M raised

Biotech

Healthcare

Medical Devices

Headquarters: Tempe, Arizona
Employees: 11–50
Founded: 2017
Business Model: B2B

Website: necteromedical.com
Total Funding: $115.5M
Last Round: $96.0M Series DApr 2024
Rounds: 2

About

Nectero Medical (now Nectero Therapeutics) is a clinical-stage biotech company developing the Nectero EAST® System, a minimally invasive endovascular procedure that delivers a stabilizing agent to strengthen the aortic wall and slow growth of small to medium-sized abdominal aortic aneurysms. The company received FDA Fast Track and Breakthrough Therapy designations in 2023 and raised a $94M Series D to advance its Phase II/III trial.

Summary

Nectero Medical is a Biotech company based in Tempe, United States, founded in 2017. It has raised $115.5M in total across 2 rounds, most recently a $96.0M Series D round in Apr 2024. Investors include Boston Scientific Corporation, Shiv Chaudhary and BioStar Capital.